New Advances on Zika Virus Research

Zika virus (ZIKV) is a mosquito-borne member of the Flaviviridae family that historically has been associated with mild febrile illness. However, the recent outbreaks in Brazil in 2015 and its rapid spread throughout South and Central America and the Caribbean, together with its association with sev...

Full description

Saved in:
Bibliographic Details
Main Author: Martinez-Sobrido, Luis (auth)
Other Authors: Almazan Toral, Fernando (auth)
Format: Electronic Book Chapter
Language:English
Published: MDPI - Multidisciplinary Digital Publishing Institute 2019
Subjects:
eye
IgA
NS5
EQA
NHP
Online Access:DOAB: download the publication
DOAB: description of the publication
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000naaaa2200000uu 4500
001 doab_20_500_12854_54549
005 20210211
003 oapen
006 m o d
007 cr|mn|---annan
008 20210211s2019 xx |||||o ||| 0|eng d
020 |a books978-3-03897-765-0 
020 |a 9783038977643 
040 |a oapen  |c oapen 
024 7 |a 10.3390/books978-3-03897-765-0  |c doi 
041 0 |a eng 
042 |a dc 
072 7 |a M  |2 bicssc 
100 1 |a Martinez-Sobrido, Luis  |4 auth 
700 1 |a Almazan Toral, Fernando  |4 auth 
245 1 0 |a New Advances on Zika Virus Research 
260 |b MDPI - Multidisciplinary Digital Publishing Institute  |c 2019 
300 |a 1 electronic resource (552 p.) 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
506 0 |a Open Access  |2 star  |f Unrestricted online access 
520 |a Zika virus (ZIKV) is a mosquito-borne member of the Flaviviridae family that historically has been associated with mild febrile illness. However, the recent outbreaks in Brazil in 2015 and its rapid spread throughout South and Central America and the Caribbean, together with its association with severe neurological disorders-including fetal microcephaly and Guillain-Barré syndrome in adults-have changed the historic perspective of ZIKV. Currently, ZIKV is considered an important public health concern that has the potential to affect millions of people worldwide. The significance of ZIKV in human health and the lack of approved vaccines and/or antiviral drugs to combat ZIKV infection have triggered a global effort to develop effective countermeasures to prevent and/or treat ZIKV infection. In this Special Issue of Viruses, we have assembled a collection of 32 research and review articles that cover the more recent advances on ZIKV molecular biology, replication and transmission, virus-host interactions, pathogenesis, epidemiology, vaccine development, antivirals, and viral diagnosis. 
540 |a Creative Commons  |f https://creativecommons.org/licenses/by-nc-nd/4.0/  |2 cc  |4 https://creativecommons.org/licenses/by-nc-nd/4.0/ 
546 |a English 
650 7 |a Medicine  |2 bicssc 
653 |a microRNAs 
653 |a antivirals 
653 |a reverse genetics 
653 |a nucleic acid computation 
653 |a viral pathogenesis 
653 |a plaque reduction neutralization test 
653 |a clinical trials 
653 |a viral genetic variation 
653 |a viral fitness 
653 |a pregnancy 
653 |a type I IFN antagonist 
653 |a prM-E proteins 
653 |a eye 
653 |a replicon 
653 |a antiviral responses 
653 |a Bacterial artificial chromosome 
653 |a gene expression 
653 |a NS1 protein 
653 |a viral permissiveness 
653 |a ZIKV-host interactions 
653 |a reporter virus 
653 |a viral persistence 
653 |a blood-retinal barrier 
653 |a virus like particles 
653 |a emerging arbovirus 
653 |a Non-human primates 
653 |a heme-oxygenase 1 
653 |a mosquito surveillance 
653 |a antiviral compounds 
653 |a ZIKV-associated neurologic disorders 
653 |a external quality assessment 
653 |a outbreak control 
653 |a therapeutics 
653 |a cryptic promoter silencing 
653 |a testis 
653 |a neurons 
653 |a mutagenesis 
653 |a RNA-seq 
653 |a microsphere immunoassay 
653 |a host-directed antivirals 
653 |a molecular diagnostics 
653 |a Bayesian analyses 
653 |a astrocytomas 
653 |a Full-length cDNA infectious clones 
653 |a viral pathogenicity 
653 |a neural progenitor cells 
653 |a full-length molecular clone 
653 |a antiviral 
653 |a multiplex nucleic acid detection 
653 |a Asian-lineage 
653 |a nucleic acid strand exchange 
653 |a IgA 
653 |a African-lineage 
653 |a vaccines 
653 |a Zika 
653 |a research models and tools 
653 |a immune response 
653 |a IgG avidity tests 
653 |a polymerase chain reaction 
653 |a Asian lineage 
653 |a sexual transmission 
653 |a TLR7/8 
653 |a neuropathogenesis 
653 |a cross-reactions 
653 |a genetic variability 
653 |a mosquito 
653 |a ZIKV 
653 |a infectious cDNA 
653 |a prostate 
653 |a host genetic variation 
653 |a monoclonal antibodies 
653 |a optimised 
653 |a anti-viral immunity 
653 |a QCMD 
653 |a arbovirus 
653 |a FSS13025 
653 |a MR766 
653 |a NS5 
653 |a EQA 
653 |a testicular cells 
653 |a virus attachment 
653 |a flavivirus 
653 |a mosquito-borne flavivirus 
653 |a dsRNA 
653 |a boolean logic-processing nucleic acid probes 
653 |a Ziks virus 
653 |a viral replication 
653 |a Aedes aegypti 
653 |a infection 
653 |a natural history 
653 |a infectious RNA 
653 |a zika virus 
653 |a chimeric viruses 
653 |a subgenomic replicon 
653 |a replication 
653 |a human brain glial cells 
653 |a microglia cells 
653 |a hepatocytes 
653 |a bacterial artificial chromosome 
653 |a detoxification and immune system responses 
653 |a testes 
653 |a dengue viruses 
653 |a Zika virus 
653 |a insecticide resistance 
653 |a NS2A protein 
653 |a plasmid toxicity 
653 |a cell surface receptors 
653 |a serology 
653 |a viral evolution 
653 |a laboratory preparedness 
653 |a flaviviruses 
653 |a Tet-inducible 
653 |a dengue virus 
653 |a diagnosis 
653 |a assay standardization 
653 |a infectious clone 
653 |a ELISA 
653 |a innate response 
653 |a congenital Zika syndrome 
653 |a secondary infections 
653 |a apoptosis 
653 |a viral survival 
653 |a ocular 
653 |a validated 
653 |a rhesus macaques 
653 |a neuroinflammation 
653 |a placenta cells 
653 |a NHP 
653 |a Zika virus (ZIKV) 
653 |a point-of-care diagnostics 
653 |a isothermal nucleic acid amplification 
653 |a microcephaly 
653 |a cytopathic effects 
653 |a indirect immunofluorescence 
653 |a fetal infection 
653 |a therapy 
653 |a siRNA 
653 |a viral counteraction 
653 |a neural cells 
653 |a silvestrol 
653 |a eIF4A 
856 4 0 |a www.oapen.org  |u https://mdpi.com/books/pdfview/book/1201  |7 0  |z DOAB: download the publication 
856 4 0 |a www.oapen.org  |u https://directory.doabooks.org/handle/20.500.12854/54549  |7 0  |z DOAB: description of the publication